The interview guide included questions exploring participants' insights on how genetic risk status was delivered, how the information influenced their motivation for lifestyle modification to reduce NAFLD risk, and any knowledge sharing that occurred with family members after learning of their PNPLA3 risk status. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.